Eclipse’ US$31.4 Million Series B Investment in Capstan Medical

Latham & Watkins advises Eclipse on investment in Capstan Medical.Capstan Medical, a developer of minimally invasive technology to address heart valve disease, closed an oversubscribed US$31.4…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Marco Zingaro

This content is for Standard 1 Year members only.
Login Join Now